Rate of motor progression in Parkinson's disease: a systematic review and meta-analysis.

Autor: Pauwels, Ayla, Phan, Albert L. G., Ding, Catherine, Phan, Thanh G., Kempster, Peter A.

Publikováno v: Frontiers in Neurology; 2024, p1-13, 15p

Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans.

Autor: Heinonen EH; Orion-Farmos, Turku, Finland., Anttila MI, Karnani HL, Nyman LM, Vuorinen JA, Pyykkö KA, Lammintausta RA

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 1997 Jul; Vol. 37 (7), pp. 602-9.

GENETIC EVIDENCE FOR REPRODUCTIVE ISOLATION AND MULTIPLE ORIGINS OF SYMPATRIC TROPHIC ECOTYPES OF WHITEFISH (COREGONUS).

Autor: Bernatchez L; Département de biologie, GIROQ Université Laval, Sainte-Foy, Québec, G1K 7P4, Canada., Vuorinen JA; Department of Biology, University of Joensuu, P.O. Box 111, FIN 80101, Joensuu, Finland., Bodaly RA; Canada Department of Fisheries and Oceans, Freshwater Institute, 501 University Crescent, Winnipeg, Manitoba, R3T 2N6, Canada., Dodson JJ; Département de biologie, Université Laval, Sainte-Foy, Québec, G1K 7P4, Canada.

Publikováno v: Evolution; international journal of organic evolution [Evolution] 1996 Apr; Vol. 50 (2), pp. 624-635.

Selegiline in de novo parkinsonian patients: the Finnish study.

Autor: Myllylä VV; Department of Neurology, University of Oulu, Finland., Sotaniemi KA, Vuorinen JA, Heinonen EH

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 1993; Vol. 8 Suppl 1, pp. S41-4.

Selegiline as a primary treatment of Parkinson's disease.

Autor: Myllylä VV; Department of Neurology, University of Oulu, Finland., Sotaniemi KA, Vuorinen JA, Heinonen EH

Publikováno v: Acta neurologica Scandinavica. Supplementum [Acta Neurol Scand Suppl] 1991; Vol. 136, pp. 70-2.